|
1
|
Travis WD, Brambilla E, Noguchi M, et al:
International Association for the Study of Lung Cancer/American
Thoracic Society/European Respiratory Society international
multidisciplinary classification of lung adenocarcinoma. J Thorac
Oncol. 6:244–285. 2011. View Article : Google Scholar
|
|
2
|
Jemal A, Ma J, Rosenberg PS, Siegel R and
Anderson WF: Increasing lung cancer death rates among young women
in southern and midwestern States. J Clin Oncol. 30:2739–2744.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Marshall E: Cancer research and the $90
billion metaphor. Science. 331:1540–1541. 2011.
|
|
4
|
Boeri M, Pastorino U and Sozzi G: Role of
microRNAs in lung cancer: microRNA signatures in cancer prognosis.
Cancer J. 18:268–274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu Y, Crawford M, Mao Y, et al:
Therapeutic delivery of microRNA-29b by cationic lipoplexes for
lung cancer. Mol Ther Nucleic Acids. 2:e842013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kesanakurti D, Maddirela DR, Chittivelu S,
Rao JS and Chetty C: Suppression of tumor cell invasiveness and in
vivo tumor growth by microRNA-874 in non-small cell lung cancer.
Biochem Biophys Res Commun. 434:627–633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miao LJ, Huang SF, Sun ZT, et al: MiR-449c
targets c-Myc and inhibits NSCLC cell progression. FEBS Lett.
587:1359–1365. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang H, Zhao M, Lv Z, et al: MiR-138
inhibits tumor growth through repression of EZH2 in non-small cell
lung cancer. Cell Physiol Biochem. 31:56–65. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu J, Lu KH, Liu ZL, Sun M, De W and Wang
ZX: MicroRNA-100 is a potential molecular marker of non-small cell
lung cancer and functions as a tumor suppressor by targeting
polo-like kinase 1. BMC Cancer. 12:5192012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang M, Shen H, Qiu C, et al: High
expression of miR-21 and miR-155 predicts recurrence and
unfavourable survival in non-small cell lung cancer. Eur J Cancer.
49:604–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mallick R, Patnaik SK and Yendamuri S:
MicroRNAs and lung cancer: biology and applications in diagnosis
and prognosis. J Carcinog. 9:2010. View Article : Google Scholar
|
|
12
|
Su N, Qiu H, Chen Y, Yang T, Yan Q and Wan
X: miR-205 promotes tumor proliferation and invasion through
targeting ESRRG in endometrial carcinoma. Oncol Rep. 29:2297–2302.
2013.PubMed/NCBI
|
|
13
|
Xie H, Zhao Y, Caramuta S, Larsson C and
Lui WO: miR-205 expression promotes cell proliferation and
migration of human cervical cancer cells. PLoS One. 7:e469902012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Du L and Pertsemlidis A: microRNA
regulation of cell viability and drug sensitivity in lung cancer.
Expert Opin Biol Ther. 12:1221–1239. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nana-Sinkam SP and Croce CM: Clinical
applications for microRNAs in cancer. Clin Pharmacol Ther.
93:98–104. 2013. View Article : Google Scholar
|
|
16
|
Vosa U, Vooder T, Kolde R, Vilo J,
Metspalu A and Annilo T: Meta-analysis of microRNA expression in
lung cancer. Int J Cancer. 132:2884–2893. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang D, Wang S, Liu Q, Wang M, Wang C and
Yang H: SZ-685C exhibits potent anticancer activity in both
radiosensitive and radioresistant NPC cells through the
miR-205-PTEN-Akt pathway. Oncol Rep. 29:2341–2347. 2013.PubMed/NCBI
|
|
18
|
Wu H, Zhu S and Mo YY: Suppression of cell
growth and invasion by miR-205 in breast cancer. Cell Res.
19:439–448. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boll K, Reiche K, Kasack K, et al:
MiR-130a, miR-203 and miR-205 jointly repress key oncogenic
pathways and are downregulated in prostate carcinoma. Oncogene.
32:277–285. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qin AY, Zhang XW, Liu L, et al: MiR-205 in
cancer: an angel or a devil? Eur J Cell Biol. 92:54–60. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamada KM and Araki M: Tumor suppressor
PTEN: modulator of cell signaling, growth, migration and apoptosis.
J Cell Sci. 114:2375–2382. 2001.PubMed/NCBI
|
|
22
|
Panagiotou I, Tsiambas E, Lazaris AC, et
al: PTEN expression in non small cell lung carcinoma based on
digitized image analysis. J BUON. 17:719–723. 2012.PubMed/NCBI
|
|
23
|
Li G, Zhao J, Peng X, Liang J, Deng X and
Chen Y: The mechanism involved in the loss of PTEN expression in
NSCLC tumor cells. Biochem Biophys Res Commun. 418:547–552. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qu C, Liang Z, Huang J, et al: MiR-205
determines the radioresistance of human nasopharyngeal carcinoma by
directly targeting PTEN. Cell Cycle. 11:785–796. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karaayvaz M, Zhang C, Liang S, Shroyer KR
and Ju J: Prognostic significance of miR-205 in endometrial cancer.
PLoS One. 7:e351582012. View Article : Google Scholar : PubMed/NCBI
|
